Jpmorgan Chase & CO Humacyte, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Humacyte, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 51,835 shares of HUMA stock, worth $263,840. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,835

Previous 52,191 0.68%

Holding current value

$263,840

Previous $250,000 12.4%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 26, 2024	SELL	$5.11 - $9.46 $1,819 - $3,367	-356 Reduced 0.68%	51,835 $281,000
Q3 2024 Nov 08, 2024	SELL	$5.11 - $9.46 $1,819 - $3,367	-356 Reduced 0.68%	51,835 $281,000
Q2 2024 Dec 26, 2024	BUY	$2.87 - $9.1 $1,021 - $3,239	356 Added 0.69%	52,191 $250,000
Q2 2024 Aug 12, 2024	BUY	$2.87 - $9.1 $12,513 - $39,676	4,360 Added 9.12%	52,191 $250,000
Q1 2024 Dec 26, 2024	SELL	$2.57 - $4.84 $10,290 - $19,379	-4,004 Reduced 7.72%	47,831 $148,000
Q1 2024 May 10, 2024	SELL	$2.57 - $4.84 $36,342 - $68,442	-14,141 Reduced 22.82%	47,831 $148,000
Q4 2023 Dec 26, 2024	BUY	$1.99 - $3.12 $20,172 - $31,627	10,137 Added 19.56%	61,972 $176,000
Q4 2023 Feb 12, 2024	BUY	$1.99 - $3.12 $750 - $1,176	377 Added 0.61%	61,972 $176,000
Q3 2023 Nov 14, 2023	BUY	$2.75 - $4.48 $22,189 - $36,149	8,069 Added 15.07%	61,595 $180,000
Q2 2023 Aug 11, 2023	BUY	$2.86 - $4.97 $7,287 - $12,663	2,548 Added 5.0%	53,526 $153,000
Q1 2023 May 18, 2023	BUY	$2.11 - $3.25 $95,015 - $146,350	45,031 Added 757.21%	50,978 $157,000
Q1 2023 May 11, 2023	SELL	$2.11 - $3.25 $66,159 - $101,903	-31,355 Reduced 84.06%	5,947 $18,000
Q4 2022 Feb 13, 2023	BUY	$2.02 - $3.62 $39,963 - $71,618	19,784 Added 112.94%	37,302 $79,000
Q3 2022 Nov 14, 2022	BUY	$1.22 - $5.14 $3,577 - $15,070	2,932 Added 20.1%	17,518 $58,000
Q2 2022 Aug 11, 2022	BUY	$3.21 - $7.86 $6,529 - $15,987	2,034 Added 16.2%	14,586 $47,000
Q1 2022 May 11, 2022	SELL	$4.65 - $7.4 $8,583 - $13,660	-1,846 Reduced 12.82%	12,552 $89,000
Q4 2021 Feb 10, 2022	BUY	$7.25 - $11.6 $104,385 - $167,016	14,398 New	14,398 $105,000

Others Institutions Holding HUMA

# of Institutions

150

Shares Held

35.1M

Call Options Held

279K

Put Options Held

607K

View Full List

About Humacyte, Inc.

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $524M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

More about HUMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Humacyte, Inc. Transaction History